TS-161 / Taisho  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TS-161 / Taisho
NCT04821271: Antidepressant Effects of TS-161 in Treatment-Resistant Depression

Completed
2
11
US
Placebo, TS-161 (50 - 100 mg)
National Institute of Mental Health (NIMH), Taisho Pharmaceutical Co., Ltd.
Major Depressive Disorder, Treatment-Resistant Depression, Depression
05/24
05/24

Download Options